Oral Carbon Monoxide Enhances Autophagy Modulation in Prostate, Pancreatic, and Lung Cancers
Abstract: Modulation of autophagy, specifically its inhibition, stands to transform the capacity to effectively treat a broad range of cancers. However, the clinical efficacy of autophagy inhibitors has been inconsistent. To delineate clinical and epidemiological features associated with autophagy inhibition and a positive oncological clinical response, a retrospective analysis of patients is conducted treated with hydroxychloroquine, a known autophagy inhibitor. A direct correlation between smoking status and inhibition of autophagy with hydroxychloroquine is identified. Recognizing that smoking is associated with elevated circulating levels of carbon monoxide (CO), it is hypothesized that supplemental CO can amplify autophagy inhibition. A novel, gas‐entrapping material containing CO in a pre‐clinical model is applied and demonstrated that CO can dramatically increase the cytotoxicity of autophagy inhibitors and significantly inhibit the growth of tumors when used in combination. These data support the notion that safe, therapeutic levels of CO can markedly enhance the efficacy of autophagy inhibitors, opening a promising new frontier in the quest to improve cancer therapies.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Oral Carbon Monoxide Enhances Autophagy Modulation in Prostate, Pancreatic, and Lung Cancers ; day:12 ; month:12 ; year:2023 ; extent:13
Advanced science ; (12.12.2023) (gesamt 13)
- Creator
-
Bi, Jianling
Witt, Emily
McGovern, Megan K.
Cafi, Arielle B.
Rosenstock, Lauren L.
Pearson, Anna B.
Brown, Timothy J.
Karasic, Thomas B.
Absler, Lucas C.
Machkanti, Srija
Boyce, Hannah
Gallo, David
Becker, Sarah L.
Ishida, Keiko
Jenkins, Joshua
Hayward, Alison
Scheiflinger, Alexandra
Bodeker, Kellie L.
Kumar, Ritesh
Shaw, Scott K.
Jabbour, Salma K.
Lira, Vitor A.
Henry, Michael D.
Tift, Michael S.
Otterbein, Leo E.
Traverso, Giovanni
Byrne, James D.
- DOI
-
10.1002/advs.202308346
- URN
-
urn:nbn:de:101:1-2023121214294235477619
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bi, Jianling
- Witt, Emily
- McGovern, Megan K.
- Cafi, Arielle B.
- Rosenstock, Lauren L.
- Pearson, Anna B.
- Brown, Timothy J.
- Karasic, Thomas B.
- Absler, Lucas C.
- Machkanti, Srija
- Boyce, Hannah
- Gallo, David
- Becker, Sarah L.
- Ishida, Keiko
- Jenkins, Joshua
- Hayward, Alison
- Scheiflinger, Alexandra
- Bodeker, Kellie L.
- Kumar, Ritesh
- Shaw, Scott K.
- Jabbour, Salma K.
- Lira, Vitor A.
- Henry, Michael D.
- Tift, Michael S.
- Otterbein, Leo E.
- Traverso, Giovanni
- Byrne, James D.
Other Objects (12)
Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer
Role of autophagy in pancreatic disease
Hypoxia enhances autophagy level of human sperms
Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers
Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Autophagy in cancers including brain tumors: role of MicroRNAs
Reduction of spermine synthase enhances autophagy to suppress Tau accumulation
Impaired proteasomal degradation enhances autophagy via hypoxia signaling in Drosophila
Targeting autophagy as a therapeutic strategy against pancreatic cancer
Effective hybrid feature selection using different bootstrap enhances cancers classification performance
Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers
Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer
Role of autophagy in pancreatic disease
Hypoxia enhances autophagy level of human sperms
Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers
Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Autophagy in cancers including brain tumors: role of MicroRNAs
Reduction of spermine synthase enhances autophagy to suppress Tau accumulation
Impaired proteasomal degradation enhances autophagy via hypoxia signaling in Drosophila
Targeting autophagy as a therapeutic strategy against pancreatic cancer
Effective hybrid feature selection using different bootstrap enhances cancers classification performance
Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers
Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer
Role of autophagy in pancreatic disease
Hypoxia enhances autophagy level of human sperms
Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers
Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Autophagy in cancers including brain tumors: role of MicroRNAs
Reduction of spermine synthase enhances autophagy to suppress Tau accumulation
Impaired proteasomal degradation enhances autophagy via hypoxia signaling in Drosophila
Targeting autophagy as a therapeutic strategy against pancreatic cancer
Effective hybrid feature selection using different bootstrap enhances cancers classification performance